Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/01/25
End: 07/31/28
Due: 07/31/29
Phase: N/A
Priority: Normal
Start: 01/31/24
End: 12/30/25
Due: 12/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus | NCT06821399 | Yufan Wang | user2@example.com | None | 2025-02-01 | 2028-07-31 | 2029-07-31 | - | - | 2025-07-14 |
| A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM) | NCT06191328 | Yufan Wang | user2@example.com | None | 2024-01-31 | 2025-12-30 | 2026-12-30 | - | - | 2025-07-14 |